Skip Navigation

Sangamo CEO talks gene-regulation therapies partnership with Biogen

Mad Money with Jim Cramer

Sangamo CEO talks gene-regulation therapies partnership with Biogen

Sangamo Therapeutics CEO Sandy Macrae broke down the company's deal with Biogen to develop solutions for Alzheimer's and Parkinson's diseases.

06:42

Thu, Mar 5 20207:05 PM EST

Saba Capital's Boaz Weinstein on BlackRock campaign

Saba Capital's Boaz Weinstein on BlackRock campaign

35 min ago

U.S. Trade Representative Katherine Tai on raising China tariffs

U.S. Trade Representative Katherine Tai on raising China tariffs

an hour ago

Former SEC Chair Jay Clayton on meme stocks craze: It bothers me, it is 'certainly not investing'

Former SEC Chair Jay Clayton on meme stocks craze: It bothers me, it is 'certainly not investing'

an hour ago

Games Global files to withdraw U.S. IPO plans

Games Global files to withdraw U.S. IPO plans

Goldman's Sara Naison-Tarajano: Tremendous amount of growth in the market has come from 'Mag 7'

Goldman's Sara Naison-Tarajano: Tremendous amount of growth in the market has come from 'Mag 7'

Saba Capital's Boaz Weinstein on BlackRock campaign

Saba Capital's Boaz Weinstein on BlackRock campaign

35 min ago

U.S. Trade Representative Katherine Tai on raising China tariffs

U.S. Trade Representative Katherine Tai on raising China tariffs

an hour ago

Former SEC Chair Jay Clayton on meme stocks craze: It bothers me, it is 'certainly not investing'

Former SEC Chair Jay Clayton on meme stocks craze: It bothers me, it is 'certainly not investing'

an hour ago

Games Global files to withdraw U.S. IPO plans

Games Global files to withdraw U.S. IPO plans

Goldman's Sara Naison-Tarajano: Tremendous amount of growth in the market has come from 'Mag 7'

Goldman's Sara Naison-Tarajano: Tremendous amount of growth in the market has come from 'Mag 7'